Drag a card by its title · ⚙ to size, swap or remove

The company

Verastem, Inc.

VSTM · Nasdaq

Health CareBiotechnologyIn trend

VSTM stood above a rising 150-day average in 16 of the last 52 weekly readings, including each of the last 7 weeks. It is 45.7% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: In trend
Weeks in an uptrend: 7 in a row
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $1.3M
Officials’ trades on record: 4
Institutions holding: 152 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

4 disclosed lines: House 0, Senate 0, executive 4; 1 people.

Who	Did	Amount	Traded
Eric S. Lander Executive branch: Office of Government EthicsOffice of Science and Technology Policy	sold	$250k–$500k	14 Jun 2021filed 8 Sep 2021
Eric S. Lander Executive branch: Office of Government EthicsOffice of Science and Technology Policy	sold	$100k–$250k	11 Jun 2021filed 8 Sep 2021
Eric S. Lander Executive branch: Office of Government EthicsOffice of Science and Technology Policy	sold	$100k–$250k	11 Jun 2021filed 8 Sep 2021
Eric S. Lander Executive branch: Office of Government EthicsOffice of Science and Technology Policy	sold	$100k–$250k	10 Jun 2021filed 8 Sep 2021

Insiders

Buy orders, 12 months0

Sale orders, 12 months31

Buyers · sellers0 · 6

Who	Did	Shares	Traded
Daniel CalkinsChief Financial Officer	sold	2,566at $8.00	1 Oct 2026filed 2 Oct 2026
Dan PatersonPresident and CEO	sold	44,121at $8.00	1 Oct 2026filed 2 Oct 2026
Daniel CalkinsChief Financial Officer	sold	55at $7.70	21 Sep 2026filed 23 Sep 2026
Dan PatersonPresident and CEO	sold	1,302at $5.81	3 Aug 2026filed 5 Aug 2026
Daniel CalkinsChief Financial Officer	sold	4,032at $4.18	22 Jun 2026filed 24 Jun 2026
Daniel CalkinsChief Financial Officer	sold	57at $4.13	22 Jun 2026filed 24 Jun 2026
Dan PatersonPresident and CEO	sold	20,871at $4.18	22 Jun 2026filed 24 Jun 2026
Dan PatersonPresident and CEO	sold	806at $5.82	4 May 2026filed 6 May 2026
Dan PatersonPresident and CEO	sold	970at $6.69	4 Feb 2026filed 5 Feb 2026
Daniel CalkinsChief Financial Officer	sold	5,039at $7.16	12 Jan 2026filed 14 Jan 2026
Dan PatersonPresident and CEO	sold	10,321at $7.16	12 Jan 2026filed 14 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders152+4 on the quarter

New · exited33 · 29

Reported value$362.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	9,192,447$35.1M	+2,997,522+48.4%
ARMISTICE CAPITAL, LLCadded · filed 14 Aug 2026	7,024,000$26.8M	+2,432,000+53.0%
RTW INVESTMENTS, LPadded · filed 14 Aug 2026	6,635,793$25.3M	+59,487+0.9%
Deep Track Capital, LPunchanged · filed 14 Aug 2026	5,740,850$21.9M	00.0%
STATE STREET CORPadded · filed 7 Aug 2026	5,133,859$19.6M	+1,617,208+46.0%
Rosalind Advisors, Inc.added · filed 14 Aug 2026	3,986,509$15.2M	+1,848,034+86.4%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	3,851,508$14.7M	+528,738+15.9%
Nantahala Capital Management, LLCunchanged · filed 14 Aug 2026	3,584,820$13.7M	00.0%
Stonepine Capital Management, LLCadded · filed 14 Aug 2026	3,349,627$12.8M	+47,327+1.4%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	3,266,870$12.5M	+2,509,995+331.6%